BRIEF-Pharmacorp Rx Inc. Announces Second Quarter 2026 Financial Results
PharmaCorp Rx Inc PCRX.V:
PHARMACORP RX INC. ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS
PHARMACORP RX - Q2 2026 REVENUE $7.7 MILLION VERSUS $4.4 MILLION IN Q2 2025
PHARMACORP RX - Q2 2026 SAME-STORE SALES UP 3.8%, SAME-STORE PRESCRIPTION SALES UP 5.2% YEAR-OVER-YEAR
Source text: ID:nGNXbsPFdT
Further company coverage: PCRX.V
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Trade now！
You may also like
Crypto prices
More
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now